Table 3.
Summary of design strategies for SNA's programmable structure on maximizing immune system activation.
Structure | Variables in the structure | Adjuvant | Antigen | modol | Outcomes | Ref |
---|---|---|---|---|---|---|
L -SNA | Differential hydrophobic anchors between nucleic acids and liposomes (lipid-tail or cholesterol-tail) | CpG-1826 | None | RAW-Blue macrophages | The structures utilizing lipid tail-anchored nucleic acids in LSNA have greater stability as well as greater ability to activate TLR receptors than those utilizing cholesterol-anchored nucleic acids. | [207] |
L -SNA | Diacyl lipid tail | CpG-1826 | Py8119 TNBC cells lysates | Orthotopic mouse models of 4T1 & Py8119 | The use of DPPC with high Tc value as a lipid tail could improve the serum stability of L-SNA as well as the ability to activate immunity, with obvious anti-tumor effects, and inhibit the lung metastasis of TNBC cells. | [202] |
L -SNA | The Linker between antigen and SNA(Whether or not it can be cracked) | CpG | Gp100 (KVPRNQDWL) | DC cells derived from bone marrow | A cleavable traceless linker between antigen and SNA enhances activation of T cells. | [203] |
L -SNA | The Linker between peptide antigens and SNAs(The rate of cleavage) | CpG | OVA-1 | C57BL/6&OT-1 mouse splenocytes | The cleavable Linker and the ability to rapidly release antigen can enhance the immunizing effect of SNA. | [204] |
L -SNA | Location of antigen and adjuvant | CpG | Prostate cancer peptide | Syngeneic mouse models of prostate cancer | HM SNAs, which can simultaneously present antigen and adjuvant on the surface, are capable of inducing stronger anti-tumor immune responses than EM SNAs, in which the SNA core encapsulates the antigen. | [194] |
L -SNA | Location of OVA1 and OVA2 on the SNA & the way of delivery for both antigens OVA1 and OVA2. | CpG | OVA1&OVA2 | DC cells derived from bone marrow& C57BL/6 | Simultaneous delivery of both antigens with the same SNA induced stronger T cell activation than delivery of two SNAs separately. Moreover, the structure of core-coated OVA2 and externally crosslinked OVA1 significantly improved the tumor suppression effect than the structure of core-coated OVA1 and externally crosslinked OVA2. | [175] |
L -SNA | Categories of nucleic acids loaded on the surface of LSNA | CpG-A&CpG-B | None | DC cells derived from bone marrow | LSNA containing two-component CpG activated the maturation of DC cells more than mixtures of CpG-A and CpG-B and single-component LSNA containing CpG-A or CpG-B. | [205] |